Pharmsville Co., Ltd. (KOSDAQ:318010)
3,450.00
+30.00 (0.88%)
At close: Jul 31, 2026
Pharmsville Market Cap
Pharmsville has a market cap or net worth of 26.66 billion as of July 31, 2026. Its market cap has decreased by -14.71% in one year.
Market Cap
26.66B
Enterprise Value
-12.72B
Revenue
11.88B
Ranking
n/a
PE Ratio
8.92
Stock Price
3,450.00
ChartMarket Cap Chart
Since October 22, 2019, Pharmsville's market cap has decreased from 113.79B to 26.66B, a decrease of -76.57%. That is a compound annual growth rate of -19.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 26.66B | 0.44% |
| Dec 30, 2025 | 26.55B | -8.28% |
| Dec 30, 2024 | 28.94B | -57.01% |
| Dec 28, 2023 | 67.32B | -21.29% |
| Dec 29, 2022 | 85.53B | -20.44% |
| Dec 30, 2021 | 107.50B | 25.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eagle Veterinary Technology Co.,Ltd | 38.05B |
| Korean Drug | 36.66B |
| Korea Arlico Pharm | 36.25B |
| Kyung Nam Pharm | 29.43B |
| Baskhanbio Pharma | 27.30B |
| HLscience | 26.89B |
| Seoul Pharma | 23.21B |
| Daesung Microbiological Labs. | 23.18B |